Skip to content

Sacral Erector Spinae Plane Block in Transurethral Prostate Resection Surgery

Effect of Sacral Erector Spinae Plane Block on Postoperative Pain in Transurethral Prostate Resection Surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06962085
Enrollment
60
Registered
2025-05-08
Start date
2025-09-05
Completion date
2026-01-08
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TURP(Transurethral Resection of Prostate)

Keywords

Bilateral sacral erector spinae plane block, Opioid consumption, Numerical pain scores, Quality of Recovery-15 (QoR-15T), TUR-P

Brief summary

The aim of this study is to investigate the effects of bilateral sacral erector spinae plane block on hemodynamic values, postoperative pain, analgesic use and patient satisfaction during operative period in Transurethral Prostate Resection surgeries under general anesthesia.

Detailed description

The study included patients who were planned to undergo transurethral prostate resection, were informed about the study, and agreed to participate in the study with their written consent, were over 18 years of age, and were in the ASA I-II risk group. Those who did not agree to participate in the study, patients under 18 years of age, and those in the ASA III-IV risk group were excluded from the study. Patients who agreed to participate in the study were divided into two groups using the sealed envelope method, and general anesthesia was applied to both groups. In the group where the block was to be applied, bilateral sacral erector spinae plane block was performed with local anesthetic (10 mL 0.25% bupivacaine + 5 mL 1% lidocaine) after the 3rd sacral intermedian crest was visualized with preoperative ultrasound. No additional intervention was performed on the patients in the control group other than the surgical procedure and general anesthesia. The hemodynamic values (noninvasive blood pressure, heart rate, peripheral oxygen saturation) of all patients during the operation, total opioid use (remifentanil) during the surgery, and NRS, nausea/vomiting and tramadol amounts at 0, 2, 4, 6, 12, and 24 hours postoperatively were recorded and the values were compared in both groups. Thus, it was aimed to evaluate the effects of sacral erector spinae plane block in transurethral prostate resection operations.

Interventions

PROCEDUREsacral erector spinae plane block group

In the block group, bilateral sacral erector spinae plane block (10 mL 0.25% bupivacaine (Marcaine %0,5. AstraZeneca Ltd, İstanbul, Türkiye) + 5 mL 1% lidocaine (Lidon 100 mg/ 5mL. ONFARMA İlaç San. Ve Tic. A.Ş, Ankara, Türkiye) will be performed in the lateral position with the help of ultrasound before surgery.

Sacral arrector spine block will not be performed in this group. After general anesthesia, hemodynamic values (noninvasive blood pressure, heart rate, peripheral oxygen saturation) and total remifentanil (Rentanil 2 mg. VEM İlaç San. Ve Tic. A.Ş, İstanbul, Türkiye) use will be recorded during the operation. Additionally, numerical pain scores and total meperidine (Aldine 100mg/2mL. VEM İlaç San. Ve Tic. A.Ş, İstanbul, Türkiye) use at 0, 2, 4, 6, 12 and 24 hours after the operation will be recorded. At the 24th hour, the Turkish version of the Quality of Recovery-15 (QoR-15T) Questionnaire will be filled out and recorded.

Sponsors

Adiyaman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Masking description

Nurses who evaluate the pain score and satisfaction survey during the postoperative follow-up of the patients will be blinded.

Intervention model description

Two groups as Control and Block groups

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who were scheduled for transurethral prostate resection, * Who agreed to participate in the study, * Who were over 18 years old * ASA I-II risk group

Exclusion criteria

* Patients who did not agree to participate in the study, * Those under 18 years old * ASA III-IV risk group

Design outcomes

Primary

MeasureTime frameDescription
postoperative opioid use24 hoursOpioid use will be recorded at 0, 2, 4, 6, 12 and 24 hours after the operation.

Secondary

MeasureTime frameDescription
intraoperative opioid useintraoperativeTotal opioid use (remifentanil) during the operation will be recorded.
numerical pain score24 hoursPostoperatively, numerical pain scores (NRS) will be recorded at 0, 2, 4, 6, 12 and 24 hours and these values will be compared and recorded in both groups. Numerical pain scores (NRS) are the scale used to measure pain intensity. This scale gives a numerical value between 0 and 10, with 0 being 'no pain' and 10 being 'worst imaginable pain'.
QoR-15T (Turkish) quality of recovery scale24 hoursThe Quality of Recovery-15 (QoR-15) at 24 hours scale is a patient-reported outcome questionnaire that measures the quality of postoperative recovery. The validity of Quality of Recovery-15 (QoR-15) has been proven in many languages. In our study, the Turkish Quality of Recovery-15 (QoR-15T) will be used to measure postoperative recovery in the Turkish population. The Turkish Quality of Recovery-15 (QoR-15T) scale consists of 2 parts and a total of 15 questions are asked to patients. Patients can score each question between 0 and 10, so the total Turkish Quality of Recovery-15 (QoR-15T) score can range from 0 to 150. A higher score indicates a better recovery quality.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026